Biotech · Private company
LTN PHARMACEUTICALS, INC.
Track this companyFree. Adds LTN PHARMACEUTICALS, INC. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- EnzalutamidePhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- GaleteronePhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- galeteronePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TOK-001Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled GaleteronePHASE1 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02729376 · fetched Nov 12, 2026
- A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCPHASE3 · TERMINATED · started Jun 1, 2015ClinicalTrials.gov NCT02438007 · fetched Nov 12, 2026
- A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate CancerPHASE2 · TERMINATED · started Dec 1, 2012ClinicalTrials.gov NCT01709734 · fetched Nov 12, 2026
- ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate CancerPHASE1 · COMPLETED · started Oct 1, 2009ClinicalTrials.gov NCT00959959 · fetched Nov 12, 2026